Literature DB >> 2681010

Signal transduction by p21ras.

C J Marshall1, A C Lloyd, J D Morris, H Paterson, B Price, A Hall.   

Abstract

Experiments using the physical loading of purified recombinant p21 ras proteins into quiescent normal cells to analyze how the proteins stimulate DNA synthesis and morphological transformation are reviewed. The results indicate that oncogenic p21ras proteins rapidly activate a protein-kinase-C-dependent pathway and a protein-kinase-C-independent pathway. The activation of protein kinase C is absolutely required for p21ras to stimulate DNA synthesis but is not required for morphological transformation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681010     DOI: 10.1002/ijc.2910440708

Source DB:  PubMed          Journal:  Int J Cancer Suppl        ISSN: 0898-6924


  5 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

Review 2.  Cell-matrix interactions during tumor invasion.

Authors:  J R Starkey
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

3.  Cellular ras gene activity is required for full neoplastic transformation by polyomavirus.

Authors:  L Raptis; R Marcellus; M J Corbley; A Krook; J Whitfield; S K Anderson; T Haliotis
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  p21ras and protein kinase C function in distinct and interdependent signaling pathways in C3H 10T1/2 fibroblasts.

Authors:  A Krook; M J Rapoport; S Anderson; H Pross; Y C Zhou; D T Denhardt; T L Delovitch; T Haliotis
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

5.  In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion.

Authors:  Stefanie Bulst; Elke Holinski-Feder; Brendan Payne; Angela Abicht; Sabine Krause; Hanns Lochmüller; Patrick F Chinnery; Maggie C Walter; Rita Horvath
Journal:  Mol Genet Metab       Date:  2012-05-03       Impact factor: 4.797

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.